Lifecore Biomedical, Inc. (LDE.F)

5,85 0,00 (0,00%) Ab 08:03AM CEST. Markt geöffnet.

Lifecore Biomedical, Inc.

3515 Lyman Boulevard
Chaska, MN 55318
United States
952 368 4300
https://www.lifecore.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 459

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. James G. Hall	CEO, President & Director	486,12k	N/A	1963
Mr. John D. Morberg	Executive VP & CFO	483,54k	N/A	1964
Dr. Albert D. Bolles Ph.D.	President of Curation Foods, Inc.	1,25M	N/A	1958
Mr. Steve W. Laninga	Vice President of Operations	N/A	N/A	N/A
Dr. Kipling Thacker Ph.D.	VP & Chief Scientist	N/A	N/A	1955
Mr. Aaron Perlitsh	Director of Internal Audit & Chief Compliance Officer	N/A	N/A	N/A
Mr. Darren M. Hieber	Senior Vice President of Corporate Development & Partnerships	N/A	N/A	N/A
Ms. Kara Morley	Senior Vice President of Human Resources	N/A	N/A	N/A
Ms. Jackie Q. Klecker	Executive VP & GM	N/A	N/A	N/A
Mr. Matt Augustson	Senior Vice President of Information Technology	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Corporate Governance

Lifecore Biomedical, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 5. Die grundlegenden Scores sind Audit: 10, Vorstand: 4, Shareholderrechte: 1, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.